November 12, 2020
Could regenerative medicine provide a new approach to diabetes care?
November is National Diabetes Month, a time to reflect on new ways to manage a chronic condition that affects young and old. Mayo Clinic is applying a regenerative lens to advancing diabetes care beyond routine blood checks and standard insulin therapy. Quinn Peterson, Ph.D.; Aleksey Matveyenko, Ph.D.; and Alexander Revzin, Ph.D., are collaborating on a […]
Tags: Aleksey Matveyenko, Alexander Revzin, beta cells, cell replacement therapy, insulin replacement therapy, islets, Mayo Clinic Center for Regenerative Medicine, Quinn Peterson, Type 1 diabetes, Type 2 diabetes
June 7, 2018
Stem Cell Differentiation for Diabetes: Alexander Revzin, Ph.D.
Alexander Revzin, Ph.D., is a professor of biomedical engineering at Mayo Clinic and recipient of a 2018 Regenerative Medicine Minnesota Research Award. He is developing microcapsules that could be used as cell carriers during differentiation of stem cells into pancreatic islets. These same capsules may also be useful as vehicles for islet transplantation. This technology […]
Tags: Alexander Revzin, Center for Regenerative Medicine, diabetes, Mayo Clinic, Medical Research, regenerative medicine, Regenerative Medicine Minnesota, stem cell differentiation, stem cells